Clinical Trial Update: Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sunitinib in combination with irradiated donor lymphocytes for metastatic kidney cancer; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Irradiated donor lymphocytes
• Sunitinib (sunitinib)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-05-31